On August 3, 2020 Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer, reported members of the executive team will present during upcoming virtual investor conferences (Press release, Kezar Life Sciences, AUG 3, 2020, View Source [SID1234562727]). The details of the presentations are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

William Blair Virtual BioTech Conference
Panel Session: Advancements in Renal Disease: Thursday, August 6, 2020 at 3:00pm EDT
Presenter: Noreen Henig, MD, Chief Medical Officer

BTIG Virtual Biotechnology Conference 2020
Presentation: Tuesday, August 11, 2020 at 1:30pm EDT
Presenter: John Fowler, Chief Executive Officer

The panel and presentation will be webcast live and may be accessed on the "Events & Presentations" section of the Company’s website at View Source Kezar Life Sciences will maintain an archived replay of the webcasts on its website for 90 days after the conference.